1. Clinical pharmacology and pharmacogenetics of gemcitabine.;Wong;Drug Metab Rev,2009
2. Inhibition of ribonucleotide reduction in CCRF-CEM cells by 2,2-difluorodeoxycytidine.;Heinemann;Mol Pharmacol,1990
3. Cellular elimination of 2,2-difluorodeoxycytidine 5-triphosphate: a mechanism of self-potentiation.;Heinemann;Cancer Res,1992
4. Gemcitabine: metabolism, mechanisms of action, and self-potentiation.;Plunkett;Semin Oncol,1995
5. Action of 2,2-difluorodeoxycytidine on DNA synthesis.;Huang;Cancer Res,1991